Abstract
Newly engineered bacterial strains propel an immune-mediated cancer therapy toward clinical applications. Hannah Martin Lawrenz reports on the latest developments.
Cite
CITATION STYLE
APA
Lawrenz, H. M. (2018). PART II: Breakthroughs in tumor-seeking bacteria. BioTechniques, 64(1), 9–10. https://doi.org/10.2144/000114625
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free